Showing 417194 results
Ordered by:
Scrip
Early Blood Cancer Data Impresses As Incyte Plots Post-Jakafi Strategy
16 Jun 2025 • By Kevin Grogan
It is early days but Incyte has caught the eye of analysts with promising first ...
Pink Sheet
EU Tests Unified Pathway For Combined Drug/IVD Studies
16 Jun 2025 • By Vibha Sharma
Sponsors planning to run multinational combined studies in the EU that involve both the clinical ...
Pink Sheet
EU Decision Time For Madrigal’s MASH Drug Resmetirom & 11 Others
16 Jun 2025 • By Eliza Slawther
The European Medicines Agency’s human medicines committee, the CHMP, is expected to decide this week ...
HBW Insight
Zentiva Strikes Deal With Aboca To Expand CHC Offering
16 Jun 2025 • By Tom Gallen
Zentiva is poised to expand its consumer health offering in Europe with the acquisition of ...
Scrip
Who Dares Wins? Roche Moves Parkinson’s Candidate Into Phase III Despite Near Miss
16 Jun 2025 • By Andrew McConaghie
Roche is taking a leap of faith with its Parkinson’s disease candidate, prasinezumab, and will ...
HBW Insight
German Associations Call For EU Green Claims Directive Trilogue Suspension
16 Jun 2025 • By David Ridley
Progress on European Union anti-greenwashing legislation should cease immediately while the impact of these rules ...
Scrip
Pipeline Watch: Eight Approvals And Ten Phase III Readouts
16 Jun 2025 • By
The table above records the past week’s major catalyst events that occurred in the late-stage ...
Medtech Insight
Prix Galien Spotlights Mental Health ‘Renaissance’ But Systemic Hurdles Persist
16 Jun 2025 • By Natasha Barrow
“We have hardly seen any innovation in mental health – even in schizophrenia,” Catherine Owen ...
Generics Bulletin
‘I Saw An Unpolished Diamond’: Iconovo CEO Wäborg On Breaking Even In 2027 And Beyond
16 Jun 2025 • By Dean Rudge
By the end of the decade, Swedish inhalation platform technology specialist Iconovo foresees at least ...
Generics Bulletin
Lupin Looks To Expand In China With Respiratory Alliance
16 Jun 2025 • By Dave Wallace
Lupin has struck a deal aimed at expanding its footprint in China, allying with local ...
Generics Bulletin
Outlook Launches Ophthalmic Bevacizumab In Germany And The UK
16 Jun 2025 • By Urtė Fultinavičiūtė
Outlook Therapeutics has launched its Lytenava (bevacizumab gamma) in Germany and the UK, after snatching ...
In Vivo
Behind The Buyout: Dispatches From The Dealmaking Table
16 Jun 2025 • By Jo Shorthouse
As pharmaceutical industry observers know, the last two years have not been kind to companies ...
HBW Insight
Over The Counter: EU Omnibus And ESG, What You Need To Know, With CEN Group’s ...
16 Jun 2025 • By David Ridley
The European Commission has put forward a series of proposals designed to simplify European Union ...
In Vivo
Crisis Or Opportunity? US MFN Policy Could Test Japan’s Appetite For Reforms
16 Jun 2025 • By Lisa Takagi
The ongoing uncertainties around US biopharmaceutical-related policies under President Donald Trump, including possible pharma trade ...
HBW Insight
TheraBreath ‘Guarantee Better’ Claim Serious, Not Puffery With Founder Prominent In Advertising
16 Jun 2025 • By Malcolm Spicer
Church & Dwight Co. Inc.’s use of TheraBreath mouthwash founder Harold Katz’s image on labeling ...
Scrip
Henlius CEO Details PD-L1 ADC’s Path To 1L Mono/Combo Therapy
16 Jun 2025 • By Dexter Jie Yan
As its PD-L1-targeting antibody-drug conjugate (ADC) candidate HLX43 moves into a global-first Phase II trial ...
Scrip
Quick Listen: Scrip’s Five Must-Know Things
16 Jun 2025 • By Ian Haydock
Join us for an audio catch-up on the major events in the global biopharma industry ...
Companies
Concentra Biosciences, LLC
16 Jun 2025 • By
https://www.concentrabiosciences.com/
Companies
Aker ASA
16 Jun 2025 • By
https://www.akerasa.com/
Companies
Fosun International Limited
14 Jun 2025 • By
https://en.fosun.com/